PharVision Advisers LLC Buys Shares of 36,328 Select Medical Holdings Co. (NYSE:SEM)

PharVision Advisers LLC purchased a new position in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 36,328 shares of the health services provider's stock, valued at approximately $685,000. Select Medical comprises approximately 0.6% of PharVision Advisers LLC's holdings, making the stock its 19th biggest holding.

A number of other large investors also recently modified their holdings of the business. Vanguard Group Inc. increased its position in Select Medical by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 12,712,990 shares of the health services provider's stock worth $239,640,000 after acquiring an additional 131,228 shares during the period. Dimensional Fund Advisors LP grew its position in Select Medical by 1.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 4,431,469 shares of the health services provider's stock worth $83,533,000 after purchasing an additional 62,585 shares during the last quarter. Invesco Ltd. lifted its stake in shares of Select Medical by 48.6% in the fourth quarter. Invesco Ltd. now owns 2,643,943 shares of the health services provider's stock valued at $49,838,000 after buying an additional 864,852 shares during the period. Principal Financial Group Inc. lifted its stake in shares of Select Medical by 1.9% in the fourth quarter. Principal Financial Group Inc. now owns 2,403,508 shares of the health services provider's stock valued at $45,310,000 after buying an additional 45,685 shares during the period. Finally, Hood River Capital Management LLC lifted its stake in shares of Select Medical by 404.8% in the fourth quarter. Hood River Capital Management LLC now owns 1,755,733 shares of the health services provider's stock valued at $33,096,000 after buying an additional 1,407,902 shares during the period. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Select Medical Price Performance

Shares of NYSE SEM traded down $0.11 during midday trading on Friday, reaching $14.38. 1,298,322 shares of the company traded hands, compared to its average volume of 901,496. The firm has a market cap of $1.85 billion, a PE ratio of 8.72, a PEG ratio of 0.64 and a beta of 1.40. The stock's 50-day simple moving average is $16.16 and its 200-day simple moving average is $20.04. Select Medical Holdings Co. has a 12 month low of $14.03 and a 12 month high of $40.98. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13.

Select Medical (NYSE:SEM - Get Free Report) last announced its earnings results on Thursday, May 1st. The health services provider reported $0.44 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.45 by ($0.01). The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.40 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The company's revenue for the quarter was down 24.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.75 EPS. As a group, equities analysts anticipate that Select Medical Holdings Co. will post 1.17 earnings per share for the current fiscal year.

Select Medical declared that its board has authorized a stock repurchase program on Thursday, May 1st that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the health services provider to buy up to 42.6% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's board of directors believes its stock is undervalued.

Select Medical Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 29th. Stockholders of record on Thursday, May 15th will be issued a $0.0625 dividend. This represents a $0.25 annualized dividend and a dividend yield of 1.74%. The ex-dividend date is Thursday, May 15th. Select Medical's payout ratio is currently 18.66%.

Insider Buying and Selling at Select Medical

In other news, CEO David S. Chernow sold 225,000 shares of the firm's stock in a transaction on Monday, April 28th. The stock was sold at an average price of $18.00, for a total value of $4,050,000.00. Following the completion of the sale, the chief executive officer now directly owns 714,516 shares in the company, valued at approximately $12,861,288. This trade represents a 23.95% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Parvinderjit S. Khanuja acquired 21,000 shares of the firm's stock in a transaction on Monday, May 5th. The shares were bought at an average cost of $15.02 per share, for a total transaction of $315,420.00. Following the acquisition, the director now owns 65,089 shares in the company, valued at approximately $977,636.78. The trade was a 47.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 11.60% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. Royal Bank of Canada cut their price target on Select Medical from $23.00 to $19.00 and set an "outperform" rating for the company in a report on Wednesday, May 7th. Benchmark upgraded shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price target on the stock in a research note on Monday, February 24th. Mizuho started coverage on shares of Select Medical in a research note on Wednesday, April 16th. They set an "outperform" rating and a $25.00 price target on the stock. Finally, Wall Street Zen raised shares of Select Medical from a "hold" rating to a "buy" rating in a report on Friday, February 21st. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $26.00.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.